Maria P Roncalés

Suggest Changes
Learn More
OBJECTIVE Patients undergoing percutaneous coronary intervention require dual antiplatelet therapy. Proton-pump inhibitor (PPI) therapy is recommended for the prevention of upper GI complications. No(More)
  • 1